These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 30743312)
41. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease. Tylicki L; Födinger M; Puttinger H; Rutkowski P; Strozecki P; Tyszko S; Rutkowski B; Hörl WH Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279 [TBL] [Abstract][Full Text] [Related]
42. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study. Song DK; Lee H; Hong YS; Sung YA BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342 [TBL] [Abstract][Full Text] [Related]
43. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome]. Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182 [TBL] [Abstract][Full Text] [Related]
44. IGF2BP2 and IGFBP3 Genotypes, Haplotypes, and Genetic Models Studies in Polycystic Ovary Syndrome. Govahi Kakhki F; Sargazi S; Montazerifar F; Majidpour M; Karajibani A; Karajibani M; Ghasemi M J Clin Lab Anal; 2024 Mar; 38(5):e25021. PubMed ID: 38468402 [TBL] [Abstract][Full Text] [Related]
45. Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction. Rallidis LS; Gialeraki A; Komporozos C; Vavoulis P; Pavlakis G; Travlou A; Lekakis I; Kremastinos DT Atherosclerosis; 2008 Sep; 200(1):115-20. PubMed ID: 18255072 [TBL] [Abstract][Full Text] [Related]
47. Association of CYP17A1 gene -34T/C polymorphism with polycystic ovary syndrome in Han Chinese population. Li L; Gu ZP; Bo QM; Wang D; Yang XS; Cai GH Gynecol Endocrinol; 2015 Jan; 31(1):40-3. PubMed ID: 25208301 [TBL] [Abstract][Full Text] [Related]
48. Association between polymorphism of MTHFR c.677C>T and risk of cardiovascular disease in Turkish population: a meta-analysis for 2.780 cases and 3.022 controls. Bozok Çetintaş V; Gündüz C Mol Biol Rep; 2014 Jan; 41(1):397-409. PubMed ID: 24264431 [TBL] [Abstract][Full Text] [Related]
49. Association between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk. Zhang XF; Liu T; Li Y; Li S Genet Mol Res; 2015 Dec; 14(4):16425-30. PubMed ID: 26662439 [TBL] [Abstract][Full Text] [Related]
50. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome. Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325 [TBL] [Abstract][Full Text] [Related]
51. Study of C677T variant of methylene tetrahydrofolate reductase gene in autistic spectrum disorder Egyptian children. Ismail S; Senna AA; Behiry EG; Ashaat EA; Zaki MS; Ashaat NA; Salah DM Am J Med Genet B Neuropsychiatr Genet; 2019 Jul; 180(5):305-309. PubMed ID: 31033224 [TBL] [Abstract][Full Text] [Related]
52. Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis. Lu Q; Dai D; Zhao W; Wang L; Yue Z; Chen X; Han G; Hao B; Yang P; Deng A; Liu J Tumour Biol; 2013 Oct; 34(5):2801-7. PubMed ID: 23765760 [TBL] [Abstract][Full Text] [Related]
53. Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients. Abdel Allah HMM; Zahran WE; El-Masry SA; El-Bendary M; Soliman AF Clin Exp Med; 2022 May; 22(2):257-267. PubMed ID: 34297238 [TBL] [Abstract][Full Text] [Related]
54. Associations of MTHFR C677T polymorphism with insulin resistance, results of NURSE Study (Nursing Unacquainted Related Stress Etiologies). Kheradmand M; Maghbooli Z; Salemi S; Sanjari M J Diabetes Metab Disord; 2017; 16():22. PubMed ID: 28540283 [TBL] [Abstract][Full Text] [Related]
55. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome. Sóter MO; Ferreira CN; Sales MF; Candido AL; Reis FM; Milagres KS; Ronda C; Silva IO; Sousa MO; Gomes KB Cytokine; 2015 Dec; 76(2):227-235. PubMed ID: 26141422 [TBL] [Abstract][Full Text] [Related]
56. No association between CYP17 -34T/C polymorphism and insulin resistance in Thai polycystic ovary syndrome. Techatraisak K; Chayachinda C; Wongwananuruk T; Dangrat C; Indhavivadhana S; Rattanachaiyanont M; Thongnoppakhun W J Obstet Gynaecol Res; 2015 Sep; 41(9):1412-7. PubMed ID: 26096606 [TBL] [Abstract][Full Text] [Related]
58. Association of single nucleotide polymorphisms in adiponectin and its receptor genes with polycystic ovary syndrome. Yoshihara K; Yahata T; Kashima K; Mikami T; Tanaka K J Reprod Med; 2009; 54(11-12):669-74. PubMed ID: 20120899 [TBL] [Abstract][Full Text] [Related]
59. Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women. Ha L; Shi Y; Zhao J; Li T; Chen ZJ PLoS One; 2015; 10(5):e0126505. PubMed ID: 25978310 [TBL] [Abstract][Full Text] [Related]
60. A cross-sectional study to assess any possible linkage of C/T polymorphism in Banerjee U; Dasgupta A; Khan A; Ghosh MK; Roy P; Rout JK; Roy P; Dhara S Indian J Med Res; 2016 Jun; 143(6):739-747. PubMed ID: 27748298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]